0001209191-18-053442.txt : 20181002
0001209191-18-053442.hdr.sgml : 20181002
20181002184349
ACCESSION NUMBER: 0001209191-18-053442
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180928
FILED AS OF DATE: 20181002
DATE AS OF CHANGE: 20181002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collins Helen Louise
CENTRAL INDEX KEY: 0001701247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 181103090
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-28
0
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001701247
Collins Helen Louise
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP and Chief Medical Officer
Common Stock
2018-09-28
4
A
0
3844
0.00
A
36073
D
Common Stock
2018-09-28
4
F
0
1906
13.92
D
34167
D
Represents shares of common stock that were delivered to the reporting person on September 28, 2018 upon achievement of a performance-based condition applicable to a restricted stock award granted to the reporting person on February 7, 2017.
/s/ Francis Sarena, Attorney-in-fact
2018-10-02